Mtech Access
Mtech Access
  • 251
  • 103 878
De-mystifying the NHS – What you need to know about the NHS as a market for your health technology
Are you a global market access lead looking to understand the challenges faced by your UK affiliates? Or do you work at a national level with responsibility for bringing a new health technology to the NHS in England? In July 2024, Global Whispers and NHS Whispers came together, to bring you an overarching view of what it takes to access the NHS with a medtech or pharmaceutical innovation.
Guest speaker Dr Faris Al-Ramadani who shared his experience of introducing new technologies to the NHS from both sides of the fence: as a PCN Clinical Director and GP Partner, and as a HealthTech and Venture Capital Consultant.
The NHS in England is complex and ever changing. Recent years have seen the introduction of new structures, new decision-makers and new priorities. If you’ve fallen out of the loop of what’s happening with the NHS, this webinar is here to help.
After de-ciphering some of the new(er) NHS terminologies and structures, we discuss:
- The key steps for introducing a new health technology to the NHS
- Who to speak to, when and where
- What to include in your value proposition to appeal to NHS decision-makers
- How to best meet key stakeholders’ needs
- The challenges of bringing a new technology to the NHS in England
Learn more about this webinar at: mtechaccess.co.uk/de-mystifying-the-nhs/
Discover more about how we can support your UK launch strategy at: mtechaccess.co.uk/strategic-uk-market-access/
Jump to:
00:00 - Introductions and welcome
06:08 - Overview of NHS organisations and structures
09:50 - Who should you talk to when launching a new health technology in the UK?
12:57 - Needs, pressures and tensions between NHS organisations
17:35 - Health inequalities and demonstrating outcomes for particular demographics
21:26 - What is the DES? What are ARRS roles?
24:50 - What evidence is most convincing?
31:43 - What timescales does the NHS look to for ROI?
33:12 - Targeting communications to HCPs and NHS stakeholders
37:17 - How can we make NHS-industry collaboration as smooth as possible?
43:16 - How not to scare off a skittish NHS?
46:35 - How are medical devices funded in community settings?
48:56 - Are there ways to speed up implementation and adoption across the NHS?
มุมมอง: 47

วีดีโอ

Where and how is medicines strategy explored in the NHS?
มุมมอง 74หลายเดือนก่อน
In this clip from a recent NHS Whispers webinar, Jack Wagstaff (Place Leader, Surrey Heartlands Health and Care Partnership, Chief Officer for North West Surrey Health and Care Alliance) discusses the management of medicines, and the impact of costs and national supply chain vulnerabilities. Jack recommends that, when considering costs, it is important to factor in other effects on the wider pa...
NHS primary care panel - the GP Contract and Operational Planning Guidance
มุมมอง 499หลายเดือนก่อน
What can we expect to see in primary care in the NHS given recent policy announcements and ongoing uncertainty? What does the new GP Contract tell us about the future of primary care? What are the biggest challenges facing primary care in 2024-25? In this webinar, Karen Cooper (Senior Consultant - NHS Insight & Interaction, Mtech Access) spoke to a panel of NHS Associates about the current stat...
Engage NHS healthcare decision-makers with RWD
มุมมอง 922 หลายเดือนก่อน
Discover how data visualisation dashboards can aid field teams in market access discussions with customers. Healthcare leaders look to real-world data (RWD) to inform decisions. Field teams presenting decision-makers with RWD within a well-designed, easy-to-use visualisation can build a case for change, while positioning themselves as a trusted partner. Watch this 20-minute discussion between I...
How do price negotiations for pharmaceuticals work in Canada?
มุมมอง 533 หลายเดือนก่อน
How do price negotiations for pharmaceuticals work in Canada? Don Husereau (Adjunct Professor of Medicine, The University of Ottawa) explains. What does this mean for your market access and pricing strategy? Email info@mtechaccess.co.uk to discuss your strategy with our experts. This clip is taken from a recent Global Whispers webinar (first broadcast live in March 2024), which is now available...
Why are CADTH conditionally approving therapies?
มุมมอง 343 หลายเดือนก่อน
Did you know that the Canadian Agency for Drugs and Technologies in Health (CADTH) can now conditionally approve a therapy, rather than offering a definite yes or no? Here, Don Husereau (Adjunct Professor of Medicine, The University of Ottawa) explains that CADTH are taking this approach when they want to see more evidence for a therapy before signing off on reimbursement, but don't want to del...
Patient access challenges for orphan medicines in the Nordic region
มุมมอง 593 หลายเดือนก่อน
In this short clip from our webinar on launching orphan drugs in secondary markets, Michelle James (Consultant - Global Market Access) tells us about HTA structures and access challenges in the Nordic region. Watch the full webinar, now available on demand and via our podcast, at: mtechaccess.co.uk/rare-disease-market-access-nordic-and-mena/
Patient access challenges for rare diseases in the MENA region
มุมมอง 304 หลายเดือนก่อน
In this short clip from our webinar on launching orphan drugs in secondary markets, Robert Taaffe (Consultant - Global Market Access) tells us about patient access challenges in the MENA region. Watch the full webinar, now available on-demand and via our podcast, at: mtechaccess.co.uk/rare-disease-market-access-nordic-and-mena/
What is a partitioned survival model?
มุมมอง 6024 หลายเดือนก่อน
What is a partitioned survival model? In this clip, Hannah Gillies (Senior Consultant - Health Economics) explains how partitioned survival models are used in health economics, along with their strengths and weaknesses for healthcare decision-making. Watch the full webinar: 'De-mystifying health economic model classifications and structures' on demand at: mtechaccess.co.uk/de-mystifying-health-...
What is a Cox regression model?
มุมมอง 3.2K4 หลายเดือนก่อน
In this clip, Daniel MacDonald (Associate Consultant - Health Economics) explains how Cox regression models are used in health economics, along with their strengths and weaknesses for healthcare decision-making. Watch the full webinar: 'De-mystifying health economic model classifications and structures' on demand at: mtechaccess.co.uk/de-mystifying-health-economic-models/ To speak to our expert...
Market access and reimbursement in Canada - changes at CADTH
มุมมอง 3194 หลายเดือนก่อน
What do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at the Canadian Agency for Drugs and Technologies in Health (CADTH) in 2024/2025? In this webinar, Clare Foy (Director - Global Market Access, Mtech Access) interviewed Don Husereau (Adjunct Professor of Medicine, The University of Ottawa). We take a look at the market access, heal...
What is a discrete event simulation in health economics?
มุมมอง 3794 หลายเดือนก่อน
Hannah Gillies (Senior Consultant - Health Economics) explains how discrete event simulations are used in health economic modelling, along with their strengths and shortcomings for healthcare decision-making. Watch the full webinar: 'De-mystifying health economic model classifications and structures' on demand at: mtechaccess.co.uk/de-mystifying-health-economic-models/ To speak to our experts a...
What is the vision for primary care provider collaboratives in the NHS?
มุมมอง 4305 หลายเดือนก่อน
In this clip, Richard Smale (Interim Director of System Co-ordination, NHS England - South West) explains that we can't focus on structural changes without first asking what difference this will make for patients. Does your proposition support the move towards provider collaboratives? Can you help provider collaboratives drive efficiency? More importantly, can your product help improve the path...
What is a Markov model? - Health economics model structures
มุมมอง 3915 หลายเดือนก่อน
In this clip, Hannah Gillies (Senior Consultant - Health Economics, Mtech Access) explains how they are used in health economics, along with their strengths and weaknesses for healthcare decision-making. Watch the full webinar (first broadcast live in January 2024): 'De-mystifying health economic model classifications and structures' on demand now at: mtechaccess.co.uk/de-mystifying-health-econ...
3 challenges your proposal must address for NHS decision-makers
มุมมอง 365 หลายเดือนก่อน
3 challenges your proposal must address for NHS decision-makers
Rare Disease market access in the MENA and Nordic regions
มุมมอง 2895 หลายเดือนก่อน
Rare Disease market access in the MENA and Nordic regions
What is a decision tree and how is it used in health economics?
มุมมอง 3885 หลายเดือนก่อน
What is a decision tree and how is it used in health economics?
Does your medical device or diagnostic empower patients?
มุมมอง 275 หลายเดือนก่อน
Does your medical device or diagnostic empower patients?
Optimising NHS funding decisions: focusing on outcomes and ROI
มุมมอง 2575 หลายเดือนก่อน
Optimising NHS funding decisions: focusing on outcomes and ROI
Opportunities to support secondary care in the NHS
มุมมอง 515 หลายเดือนก่อน
Opportunities to support secondary care in the NHS
Introducing Mtech Access - Leaders in Global Pharma and Medtech Commercialisation
มุมมอง 565 หลายเดือนก่อน
Introducing Mtech Access - Leaders in Global Pharma and Medtech Commercialisation
Health economic evaluation for HTA in different markets
มุมมอง 2735 หลายเดือนก่อน
Health economic evaluation for HTA in different markets
How does funding flow in NHSE Regions?
มุมมอง 4796 หลายเดือนก่อน
How does funding flow in NHSE Regions?
NHS policy for 2024/25: strategy and engagement in a world of uncertainty
มุมมอง 2706 หลายเดือนก่อน
NHS policy for 2024/25: strategy and engagement in a world of uncertainty
Get payer input and feedback on your evidence strategy early
มุมมอง 2356 หลายเดือนก่อน
Get payer input and feedback on your evidence strategy early
De-mystifying health economic model classifications and structures
มุมมอง 9767 หลายเดือนก่อน
De-mystifying health economic model classifications and structures
Is it worth investing time to launch in NHS Wales?
มุมมอง 197 หลายเดือนก่อน
Is it worth investing time to launch in NHS Wales?
How does specialised commissioning work in Wales?
มุมมอง 267 หลายเดือนก่อน
How does specialised commissioning work in Wales?
6 key early decisions when launching new Pharma and Medtech products
มุมมอง 2377 หลายเดือนก่อน
6 key early decisions when launching new Pharma and Medtech products
What would the NHS in Wales want to see from an industry partner?
มุมมอง 2167 หลายเดือนก่อน
What would the NHS in Wales want to see from an industry partner?